AR002272A1 - Uso de amidas de fenilciclohexilcarboxilicos - Google Patents
Uso de amidas de fenilciclohexilcarboxilicosInfo
- Publication number
- AR002272A1 AR002272A1 ARP960101106A AR10110696A AR002272A1 AR 002272 A1 AR002272 A1 AR 002272A1 AR P960101106 A ARP960101106 A AR P960101106A AR 10110696 A AR10110696 A AR 10110696A AR 002272 A1 AR002272 A1 AR 002272A1
- Authority
- AR
- Argentina
- Prior art keywords
- phenylcyclohexylcarboxylic
- amides
- medicaments
- restenosis
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Las amidas de ácidos fenilciclohexilcarboxílicos de fórmula (I) conocidas, son adecuadas como sustancia activa en medicamentos, especialmente enmedicamentos para el tratamiento de la restenosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19503160A DE19503160A1 (de) | 1995-02-01 | 1995-02-01 | Verwendung von Phenylcyclohexylcarbonsäureamiden |
Publications (1)
Publication Number | Publication Date |
---|---|
AR002272A1 true AR002272A1 (es) | 1998-03-11 |
Family
ID=7752849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP960101106A AR002272A1 (es) | 1995-02-01 | 1996-01-22 | Uso de amidas de fenilciclohexilcarboxilicos |
Country Status (31)
Country | Link |
---|---|
US (1) | US5935983A (es) |
EP (1) | EP0725064A1 (es) |
JP (1) | JPH08253453A (es) |
KR (1) | KR960031442A (es) |
CN (1) | CN1137380A (es) |
AR (1) | AR002272A1 (es) |
AU (1) | AU710235B2 (es) |
BG (2) | BG63044B1 (es) |
CA (1) | CA2168317A1 (es) |
CZ (1) | CZ29196A3 (es) |
DE (1) | DE19503160A1 (es) |
DZ (1) | DZ1986A1 (es) |
EE (1) | EE9600023A (es) |
FI (1) | FI960425A (es) |
HR (1) | HRP960017A2 (es) |
HU (1) | HUP9600227A3 (es) |
IL (1) | IL116931A (es) |
MA (1) | MA23794A1 (es) |
NO (1) | NO309841B1 (es) |
NZ (1) | NZ280905A (es) |
PL (1) | PL312546A1 (es) |
RO (1) | RO117256B1 (es) |
RU (1) | RU2158261C2 (es) |
SG (1) | SG42329A1 (es) |
SK (1) | SK13796A3 (es) |
SV (1) | SV1996000008A (es) |
TN (1) | TNSN96016A1 (es) |
TW (1) | TW448176B (es) |
UA (1) | UA35623C2 (es) |
YU (1) | YU5896A (es) |
ZA (1) | ZA96725B (es) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6911462B2 (en) * | 1998-05-22 | 2005-06-28 | Avanir Pharmaceuticals | Benzimidazole compounds for regulating IgE |
DE19924818A1 (de) * | 1999-05-29 | 2000-11-30 | Bayer Ag | Substituierte Phenylcyclohexancarbonsäureamide |
DE19924819A1 (de) * | 1999-05-29 | 2000-11-30 | Bayer Ag | Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren) |
CZ20032691A3 (en) * | 2001-03-12 | 2004-04-14 | Avanir Pharmaceuticals | Benzimidazole compounds for modulating ige and inhibiting cellular proliferation |
DE10150310A1 (de) * | 2001-10-11 | 2003-04-24 | Bayer Ag | Substituierte Piperazincyclohexancarbonsäureamide und ihre Verwendung |
US6934951B2 (en) | 2002-01-17 | 2005-08-23 | Intel Corporation | Parallel processor with functional pipeline providing programming engines by supporting multiple contexts and critical section |
TW200304820A (en) * | 2002-03-25 | 2003-10-16 | Avanir Pharmaceuticals | Use of benzimidazole analogs in the treatment of cell proliferation |
TW200400040A (en) * | 2002-05-17 | 2004-01-01 | Wyeth Corp | Hormone replacement therapy |
WO2004024655A2 (en) | 2002-09-12 | 2004-03-25 | Avanir Pharmaceuticals | Phenyl-indole compounds for modulating ige and inhibiting cellular proliferation |
TWI276631B (en) * | 2002-09-12 | 2007-03-21 | Avanir Pharmaceuticals | Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation |
AU2004263190A1 (en) * | 2003-08-08 | 2005-02-17 | Avanir Pharmaceuticals | Selective pharmacologic inhibition of protein trafficking and related methods of treating human diseases |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4226109A1 (de) * | 1992-08-07 | 1994-02-10 | Bayer Ag | Verwendung von ASS zur Hemmung von Plaquebildung |
DE4304455A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate |
US5358959A (en) * | 1993-02-18 | 1994-10-25 | President And Fellows Of Harvard University | Methods for treating arteriosclerosis |
DE4401893A1 (de) * | 1994-01-24 | 1995-07-27 | Bayer Ag | Substituierte Arylharnstoffe |
-
1995
- 1995-02-01 DE DE19503160A patent/DE19503160A1/de not_active Withdrawn
-
1996
- 1996-01-15 HR HR19503160.1A patent/HRP960017A2/hr not_active Application Discontinuation
- 1996-01-19 EP EP96100760A patent/EP0725064A1/de not_active Withdrawn
- 1996-01-22 AR ARP960101106A patent/AR002272A1/es not_active Application Discontinuation
- 1996-01-22 TW TW085100684A patent/TW448176B/zh active
- 1996-01-26 RO RO96-00152A patent/RO117256B1/ro unknown
- 1996-01-29 CA CA002168317A patent/CA2168317A1/en not_active Abandoned
- 1996-01-29 JP JP8033174A patent/JPH08253453A/ja active Pending
- 1996-01-29 NZ NZ280905A patent/NZ280905A/en unknown
- 1996-01-29 IL IL11693196A patent/IL116931A/xx not_active IP Right Cessation
- 1996-01-30 BG BG100326A patent/BG63044B1/bg unknown
- 1996-01-30 BG BG103820/99A patent/BG103820A/bg unknown
- 1996-01-30 YU YU5896A patent/YU5896A/sh unknown
- 1996-01-30 UA UA96010375A patent/UA35623C2/uk unknown
- 1996-01-30 FI FI960425A patent/FI960425A/fi unknown
- 1996-01-30 AU AU42240/96A patent/AU710235B2/en not_active Ceased
- 1996-01-30 PL PL96312546A patent/PL312546A1/xx unknown
- 1996-01-31 EE EE9600023A patent/EE9600023A/xx unknown
- 1996-01-31 SK SK137-96A patent/SK13796A3/sk unknown
- 1996-01-31 ZA ZA96725A patent/ZA96725B/xx unknown
- 1996-01-31 RU RU96101800/04A patent/RU2158261C2/ru active
- 1996-01-31 KR KR1019960002344A patent/KR960031442A/ko not_active Application Discontinuation
- 1996-01-31 CZ CZ96291A patent/CZ29196A3/cs unknown
- 1996-01-31 DZ DZ960027A patent/DZ1986A1/fr active
- 1996-01-31 NO NO960414A patent/NO309841B1/no not_active IP Right Cessation
- 1996-02-01 HU HU9600227A patent/HUP9600227A3/hu unknown
- 1996-02-01 SG SG1996000776A patent/SG42329A1/en unknown
- 1996-02-01 TN TNTNSN96016A patent/TNSN96016A1/fr unknown
- 1996-02-01 SV SV1996000008A patent/SV1996000008A/es unknown
- 1996-02-01 CN CN96102574A patent/CN1137380A/zh active Pending
- 1996-02-01 MA MA24149A patent/MA23794A1/fr unknown
-
1997
- 1997-10-24 US US08/960,075 patent/US5935983A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT923570E (pt) | Amidas de acidos piridil-alcenoicos e piridil-alcinicos como agentes citostaticos e imunossupressivos | |
ES2147320T3 (es) | Derivados de n-(3-benzofuranil)urea. | |
TR199901905T2 (xx) | 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri. | |
SV2002000097A (es) | Inhibidores de metaloproteasas ref.pcs10322/82940 /bb | |
ES2191192T3 (es) | Tienopirimidinas. | |
ATE249214T1 (de) | Pentafluorobenzensulfonamide und analoge | |
HN1998000035A (es) | Nuevos derivados del acido hexanoico | |
CY1115916T1 (el) | Αντιβιοτικες συνθεσεις για θεραπεια του αυτιου | |
AR007828A1 (es) | Compuestos derivados de piridilpirrol, procedimiento de preparacion y composiciones farmaceuticas conteniendo los mismos | |
NZ505452A (en) | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives and pharmaceuticals thereof, useful for inhibiting leukocyte function and treating inflammatory conditions | |
PT97689A (pt) | Processo para a preparacao de composicoes farmaceuticas incorporando como ingrediente activo isoxazol-4-carboxilamida e hidroxialquilideno-cianoacetamida | |
ES2138271T3 (es) | Compuestos de 6-dimetil-amino-metil-1-fenil-ciclohexano como principio activo farmaceutico. | |
DE69912606D1 (de) | 2-(purin-9-yl)-tetrahydrofuran-3,4-diol-derivate | |
SV2003001148A (es) | Derivados de benzamida tiazol y composciones farmaceuticas para inhibir la proliferacion de celulas, y metodos para su utilizacion ref. no.0097-01-sv | |
ES2089687T3 (es) | 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa. | |
MX168494B (es) | Nuevos derivados de pirazolina su preparacion y su uso como plaguisidas | |
ES2172937T3 (es) | 21-hidroxi-6,19-oxidoprogesterona(21oh-6op) como medicamento para tratar el exceso de glucocorticoides. | |
AR002272A1 (es) | Uso de amidas de fenilciclohexilcarboxilicos | |
ES2080037T1 (es) | Medicamento de uso topico con actividad cicatrizante. | |
ES2178761T3 (es) | Utilizacion de 1-hidroxi-2-piridonas para el tratamiento de infe cciones cutaneas. | |
ES2124861T3 (es) | Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa. | |
AR008860A1 (es) | Empleo de 1-hidroxi-2-piridonas para el tratamiento de la dermatitis seborreica | |
PT861250E (pt) | Derivados de amidina e de isotioureia como inibidores de oxido nitrico sintase | |
AR021694A1 (es) | Retinamidas de acido 7-aril-6-(z)heptatrienoico | |
ES2148600T3 (es) | Derivados de indol sustituidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |